Pathway Mutation Accumulate Perturbation Score: A prognostic and predictive biomarker for immunotherapy in advanced gastric cancer
The PMAPscore-based risk model is a robust tool for predicting survival and immunotherapy responses in patients with advanced GC, supporting its clinical application for treatment stratification.
Authors
- Yuming Xing
- Guihua Yang
- Huaimin Lu
- Ziyan Zhang
- Yunfei Gao
Institutions
- Beijing University of Posts and Telecommunications (CN)
- Berry Oncology (China) (CN)
- Baotou Medical College (CN)
Publication Details
- Journal
- Advances in Clinical and Experimental Medicine
- Published
- 2026-03-16
- DOI
- https://doi.org/10.17219/acem/206937
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Baotou Medical College